[Difficulties in neuroleptic treatment of schizophrenic patients].
During the treatment of schizophrenic patients with antipsychotic drugs the following difficulties must be considered: Lack of predictability of therapeutic outcome, extrapyramidal side effects, "pharmacogenic" depressions. The most important presupposition for a successful handling of these difficulties is an intensive psychopharmacological training of psychiatrists.
Woggon
B
B
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003866:Depressive Disorder / Q000139:chemically induced; D006801:Humans; D008134:Long-Term Care; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents
Schwierigkeiten bei der Neuroleptika-Behandlung schizophrener Patienten.